Alligator Bioscience AB
Immuno-oncology antibody drugs
- B2B
About Alligator Bioscience AB
Clinical-stage biotechnology company focused on creating tumor-directed immuno-oncology antibody drugs. Portfolio includes promising drug candidates, co-development projects, and out-licensed programs for cancer treatment.
Key facts
- Industry
- Biotechnology Research
- Company size
- 11–50 employees
- Headquarters
- Lund, Skåne, Sweden
- Founded
- 2001
- Revenue
- $6.5M – $51.7MTamtam estimate
- Website
- alligatorbioscience.se
Alligator Bioscience AB at a glance
Alligator Bioscience AB is a B2B company in the Biotechnology Research industry, headquartered in Lund, Skåne, Sweden.
Alligator Bioscience AB was founded in 2001.
Alligator Bioscience AB has 11–50 employees.
Alligator Bioscience AB's revenue is $6.5M – $51.7M (Tamtam estimate).
Selling to companies like Alligator Bioscience AB?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies